Last reviewed · How we verify
Fluoride Iontophoresis with Acidulated Phosphate Fluoride
Fluoride Iontophoresis with Acidulated Phosphate Fluoride is a Small molecule drug developed by Al-Azhar University. It is currently in Phase 1 development.
At a glance
| Generic name | Fluoride Iontophoresis with Acidulated Phosphate Fluoride |
|---|---|
| Sponsor | Al-Azhar University |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Exposed Hypersensitive Dentin Treated With Fluoride Iontophoresis With Remineralizing Agents (NA)
- Propolis as a Treatment for Cervical Dentin Hypersensitivity (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Fluoride Iontophoresis with Acidulated Phosphate Fluoride CI brief — competitive landscape report
- Fluoride Iontophoresis with Acidulated Phosphate Fluoride updates RSS · CI watch RSS
- Al-Azhar University portfolio CI
Frequently asked questions about Fluoride Iontophoresis with Acidulated Phosphate Fluoride
What is Fluoride Iontophoresis with Acidulated Phosphate Fluoride?
Fluoride Iontophoresis with Acidulated Phosphate Fluoride is a Small molecule drug developed by Al-Azhar University.
Who makes Fluoride Iontophoresis with Acidulated Phosphate Fluoride?
Fluoride Iontophoresis with Acidulated Phosphate Fluoride is developed by Al-Azhar University (see full Al-Azhar University pipeline at /company/al-azhar-university).
What development phase is Fluoride Iontophoresis with Acidulated Phosphate Fluoride in?
Fluoride Iontophoresis with Acidulated Phosphate Fluoride is in Phase 1.